GordonMD Global Investments LP's Form 4 filing
Pyxis Oncology, Inc.PYXS · filed Oct 2, 2026
- Accession no.
- 0000919574-26-006609
- Filed
- Oct 2, 2026, 8:35 AM ET
- Trade date
- Oct 1, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0000919574-26-006815 (Oct 9, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| GordonMD Global Investments LPCIK 0002039349 | 10% Owner |
| GordonMD Long Biased GP LLCCIK 0002103778 | 10% Owner |
| GordonMD Long Biased Master Fund LPCIK 0002103789 | 10% Owner |
| Gordon Craig DCIK 0002103811 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock, par value $0.001 per share ("Common Stock") | PPurchaseAcquired | +5,517,000 | –F2 | – | 15,541,909 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock | PPurchaseAcquired | +7,546,766 | –F2 | – | 7,546,766 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The combined public offering price for each share of common stock and accompanying Common Stock Purchase Warrant is $2.90.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.